The purpose of NORCHER is to develop, implement and evaluate models for health-service delivery that encourage equal access, high quality and cost effectiveness.
At this seminar we present research in progress, representing NORCHER’s broad field of research. We will learn about:
- whether municipal acute bed units (KAD-er) have reduced hospital admissions;
- how cancer patients’ living situation, health care utilization and healthcare costs depend on patients’ underlying cancer and sociodemographic characteristics;
- how the Nordic countries have implemented policies to improve on GP recruitments;
- the impact of telemedicine on utilization, costs and access of health services in Sweden;
- the MetAction study to illustrate challenges when doing Cost-Effectiveness analyses of precision medicine;
- three NORCHER master students will pitch the results of their master theses.
The NORCHER’s Research in Progress Seminar is held as a digital seminar the 2nd December from 9-12.
Program
| 0900 |
Welcome by Oddvar Kaarbøe |
| 0905-0935 |
Clas Rehnberg: The Impact of Telemedicine on Utilisation, Costs and Access of Health Services |
| 0935-1005 | Ole Aars: GP recruitment challenges in the Nordics |
| 1005-1010 | Master Student Ida Charlotte Holmen: Emerging trends of integrated care for children and youth’s mental health in South-Eastern Norway |
| 1010-1015 | Break |
| 1015-1045 | Terje P. Hagen: Effects of municipal acute units on hospital admissions and death rates: Evaluation of a natural experiment using register data |
| 1045-1050 |
Master Student Veerle Louise Bun: Cost and quality in the Norwegian hospital setting |
| 1050-1055 | Break |
| 1055-1125 | Gudrun Bjørnelv: Living situation, healthcare utilization and total healthcare costs the six months prior to death for all cancer decedents in Norway: are there differences between the most common cancer deaths? |
| 1125-1130 |
Master Student Fawas Tariq: Cost-effectiveness analysis of teleglaucoma screening for high-risk populations in Norway |
| 1130-1200 | Eline Aas: Cost-Effectiveness analysis of Precision Medicine: The MetAction Study |
| 1200 | Oddvar Kaarbøe closes the seminar |
